This inventor holds 1 USPTO granted patent. Top assignee: Cytokinetics, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Gustav S. Bergnes: Innovator in Quinazolinone Research
Introduction
Gustav S. Bergnes is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly through his research on quinazolinones. His work focuses on developing methods and compositions that can be utilized in treating cellular proliferative diseases.
Latest Patents
Bergnes holds a patent for "Methods and compositions utilizing quinazolinones." This patent discloses quinazolinones of formulae 1a, 1b, 1c, and 1d, which are useful for treating diseases and disorders associated with KSP kinesin activity. His innovative approach has the potential to impact therapeutic strategies significantly.
Career Highlights
Gustav S. Bergnes is currently associated with Cytokinetics, Inc., a company dedicated to advancing the field of muscle biology and developing treatments for diseases related to muscle function. His work at Cytokinetics has allowed him to collaborate with other talented professionals in the field.
Collaborations
Bergnes has worked alongside notable colleagues such as Jeffrey T. Finer and Whitney Walter Smith. Their combined expertise contributes to the innovative research environment at Cytokinetics.
Conclusion
Gustav S. Bergnes is a prominent figure in the field of medicinal chemistry, with a focus on quinazolinones and their applications in treating serious health conditions. His contributions continue to shape the landscape of therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile